Centene Reports Significant Third Quarter Loss Amid Market Challenges
Financial Overview
Centene experienced a net loss of $6.6 billion in the third quarter, primarily due to a substantial charge reflecting the company’s declining value in a challenging market. This loss is attributed to a non-cash goodwill impairment charge of $6.7 billion, which significantly impacted the company’s financial standing. However, without this charge, which does not affect Centene’s cash flows or core operations, the company would have reported a modest profit. Despite these financial setbacks, executives expressed satisfaction with Centene’s overall performance, particularly in managing rising medical costs in Medicaid and Affordable Care Act (ACA) exchanges. Following these results, Centene adjusted its full-year earnings outlook upward.
Market Context and Analyst Insights
Centene’s performance comes amid a mixed quarter for the healthcare sector, yet the company’s results surpassed Wall Street expectations, prompting TD Cowen analyst Ryan Langston to describe them as “fairly positive.” Although there was a year-over-year decline, the St. Louis-based insurer’s earnings improved on an adjusted basis compared to the second quarter, which many consider a more accurate indicator of operational performance. On a non-adjusted basis, the impairment charge overshadowed earnings as the company sought to align its balance sheet value with its market position, which has decreased significantly this year.
In July, Centene’s stock reached a decade-low following disappointing second quarter results, wiping out billions in market value. The Republican-backed “One Big Beautiful Bill,” signed into law that same month, included extensive Medicaid cuts and changes to the ACA, contributing to the impairment charge, according to company executives.
Operational Improvements and Challenges
Operationally, Centene is making strides in its turnaround efforts. The company’s medical loss ratio (MLR), which indicates spending on patient care, was 92.7% in the third quarter, an increase from 89.2% during the same period last year. Although this figure was down sequentially, it fell short of analysts’ expectations. Elevated utilization in Medicaid, which constitutes 45% of Centene’s nearly 28 million medical members, remains a primary concern. The safety-net insurance program also accounts for 52% of the company’s $44.9 billion in premium and service revenue.
Executives noted that medical spending in Medicaid has surged, particularly in behavioral health, home and community-based services, and high-cost medications. Insurers are finding it challenging to manage this increased utilization, especially given that state payment rates do not adequately cover these trends. Nonetheless, Centene’s Medicaid MLR improved in the quarter, attributed to enhanced clinical management, the exclusion of abusive providers from its networks, and a retroactive revenue increase in Florida. Efforts to advocate for higher rates with state partners have also been beneficial. CEO Sarah London indicated that Centene now expects its composite Medicaid rate for the year to be slightly higher at 5.5%, up from the previous 5% estimate.
Future Outlook for ACA and Medicaid
While utilization in Centene’s ACA business, which serves 5.8 million individuals, remains high, it has not exceeded the company’s expectations. With the potential expiration of enhanced subsidies for ACA plans at the end of 2025, Centene anticipates increased spending in the fourth quarter as enrollees seek more medical care. In preparation, the company has raised rates for its ACA plans in 2026 to account for heightened utilization and the expected end of enhanced premium tax credits. Insurers across ACA exchanges are increasing premiums in anticipation of a decline in healthier, lower-cost members when subsidies expire.
Centene achieved average rate hikes in the “mid-30s” percentage range and successfully repriced its plans in states covering 95% of its existing membership. In instances where sufficient rate increases were not attainable, Centene implemented additional measures to mitigate margin impacts.
The ongoing government shutdown is complicating the future of subsidies. While Democrats are pushing for an extension of financial assistance, Republicans argue that the issue can wait until the government reopens. Congress has a deadline to act as the subsidies expire on December 31. Delays may hinder insurers and state regulators from adjusting enrollment portals and effectively communicating changes to members facing initial price hikes.
Despite the uncertainty surrounding ACA subsidies, Centene expects its ACA business to operate at a slight loss for the year. However, London conveyed optimism about the company’s positioning for significant margin improvements in 2026.
Third Quarter Revenue Performance
In the third quarter, Centene reported revenue of $49.7 billion, reflecting an 18% increase year-over-year, driven by premium growth from an expanding member base in ACA plans and Medicaid rate hikes. The reported loss of $6.6 billion starkly contrasts with an income of $713 million during the same period last year. Looking ahead, Centene now projects adjusted earnings per share to reach at least $2 for the year, an increase from the earlier target of $1.75.